Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

110 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q3 2025.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 143M shares of 266M outstanding shares and own 53.9% of the company stock.
Largest 10 shareholders include MAK CAPITAL ONE LLC (26M shares), Blackstone Inc. (20.5M shares), Syncona Portfolio Ltd (16.6M shares), ARMISTICE CAPITAL, LLC (15.6M shares), TFG Asset Management GP Ltd (9.5M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (8.43M shares), CITADEL ADVISORS LLC (6.04M shares), RENAISSANCE TECHNOLOGIES LLC (4.88M shares), Frazier Life Sciences Management, L.P. (4.62M shares), and BlackRock, Inc. (3.47M shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.